Cargando…
Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer
BACKGROUND: Durable responses to immune-checkpoint blocking therapy (ICT) targeting programmed cell death protein-1/ligand-1 (PD-1/PD-L1) have improved outcomes for patients with triple negative breast cancer (TNBC). Unfortunately, only 19–23% of patients benefit from ICT. Hence, non-invasive strate...
Autores principales: | Liu, Wan-Ling, Zhang, Yong-Qu, Luo, Xiang-Jie, Zhu, Yuan-Yuan, Song, Liang, Ming, Zi-He, Zhang, Li-Xin, Li, Meng-Jun, Lv, Rui-Chan, Zhang, Guo-Jun, Chen, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497065/ https://www.ncbi.nlm.nih.gov/pubmed/37705867 http://dx.doi.org/10.2147/IJN.S417944 |
Ejemplares similares
-
Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes
por: Xuan, Yang, et al.
Publicado: (2021) -
Biodegradable Nanoprobe for NIR‐II Fluorescence Image‐Guided Surgery and Enhanced Breast Cancer Radiotherapy Efficacy
por: Yang, Rui‐Qin, et al.
Publicado: (2022) -
Development of a Rare Earth Nanoprobe Enables In Vivo Real-Time Detection of Sentinel Lymph Node Metastasis of Breast Cancer Using NIR-IIb Imaging
por: Zhu, Yuan-Yuan, et al.
Publicado: (2023) -
Recent advances in design of lanthanide-containing NIR-II luminescent nanoprobes
por: Yang, Yingjie, et al.
Publicado: (2021) -
Hybrid nanoprobes of bismuth sulfide nanoparticles and CdSe/ZnS quantum dots for mouse computed tomography/fluorescence dual mode imaging
por: Chen, Jun, et al.
Publicado: (2015)